title: Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.
abstract: Myelodysplastic syndrome (MDS) with del(5q) is a unique hematopoietic stem cell disease that typically follows an indolent course and demonstrates particular sensitivity to lenalidomide, a second-generation immunomodulatory agent. Early trials demonstrated rapid and durable responses leading to US Food and Drug Administration (FDA) approval in 2005. Definitive confirmatory evidence from a large phase III trial was recently published. Other recent advances include a better understanding of the pathogenesis of disease including haplodeficiency of several candidate genes, and elucidation of the lenalidomide-specific effect on two phosphatases ultimately leading to p53 degradation in the erythroid progenitors and cell cycle arrest in earlier myeloid progenitors. In this review, we describe the pathogenesis of MDS with del(5q), summarize the major clinical studies establishing the activity of lenalidomide in this population, discuss commonly encountered adverse events, and shed light on practical uses of this agent in the clinic.
authors.forename: Vu H
authors.initials: VH
authors.lastname: Duong
authors.forename: Rami S
authors.initials: RS
authors.lastname: Komrokji
authors.forename: Alan F
authors.initials: AF
authors.lastname: List
keywords: deletion 5q; lenalidomide; myelodysplastic syndromes
references.citation: J Clin Oncol. 2008 Dec 20;26(36):5943-9
references.pmid: 19018091
references.citation: J Clin Oncol. 2009 Nov 10;27(32):5404-9
references.pmid: 19805688
references.citation: Blood. 2001 Mar 1;97(5):1427-34
references.pmid: 11222390
references.citation: J Cell Biochem. 2004 Jul 1;92(4):679-90
references.pmid: 15211566
references.citation: Haematologica. 2008 Feb;93(2):315-6
references.pmid: 18245660
references.citation: Blood. 2007 Dec 15;110(13):4385-95
references.pmid: 17726160
references.citation: Leukemia. 2010 Jul;24(7):1283-9
references.pmid: 20485371
references.citation: Leukemia. 2012 Feb;26(2):356-8
references.pmid: 21799512
references.citation: Blood. 2011 Oct 6;118(14):3765-76
references.pmid: 21753188
references.citation: Blood. 2002 Jun 15;99(12):4638-41
references.pmid: 12036901
references.citation: N Engl J Med. 2005 Feb 10;352(6):549-57
references.pmid: 15703420
references.citation: Br J Haematol. 2007 May;137(3):193-205
references.pmid: 17408458
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11406-11
references.pmid: 17576924
references.citation: Haematologica. 2011 Feb;96(2):319-22
references.pmid: 21109690
references.citation: Leuk Res. 2011 Nov;35(11):1444-8
references.pmid: 21715006
references.citation: Cancer. 2006 Dec 1;107(11):2609-16
references.pmid: 17075879
references.citation: Nat Genet. 1999 Feb;21(2):169-75
references.pmid: 9988267
references.citation: Ann Hematol. 2010 Apr;89(4):365-74
references.pmid: 19855965
references.citation: Cell Cycle. 2010 Mar 1;9(5):855-6
references.pmid: 20160505
references.citation: J Clin Pharmacol. 2009 Jun;49(6):650-60
references.pmid: 19451403
references.citation: Blood. 2011 Jun 23;117(25):6876-84
references.pmid: 21527527
references.citation: N Engl J Med. 2007 Nov 22;357(21):2123-32
references.pmid: 18032762
references.citation: N Engl J Med. 2007 Nov 22;357(21):2133-42
references.pmid: 18032763
references.citation: Leukemia. 2004 Jan;18(1):113-9
references.pmid: 14586479
references.citation: J Clin Oncol. 2011 May 20;29(15):1971-9
references.pmid: 21519010
references.citation: Bioorg Med Chem Lett. 1999 Jun 7;9(11):1625-30
references.pmid: 10386948
references.citation: N Engl J Med. 2010 Sep 9;363(11):1025-37
references.pmid: 20825315
references.citation: Nature. 1974 Oct 4;251(5474):437-8
references.pmid: 4421285
references.citation: Am J Hum Genet. 2006 Dec;79(6):1110-8
references.pmid: 17186470
references.citation: Leuk Res. 2010 Apr;34(4):447-53
references.pmid: 19758696
references.citation: Leukemia. 2011 Jan;25(1):110-20
references.pmid: 20882045
references.citation: J Clin Oncol. 2007 Aug 10;25(23):3503-10
references.pmid: 17687155
references.citation: Blood. 2010 Dec 23;116(26):5838-41
references.pmid: 20876454
references.citation: J Natl Compr Canc Netw. 2011 Jan;9(1):30-56
references.pmid: 21233243
references.citation: Blood. 2007 Nov 1;110(9):3365-73
references.pmid: 17634407
references.citation: Leuk Res. 2008 Jul;32(7):1049-53
references.pmid: 18191202
references.citation: N Engl J Med. 2006 Oct 5;355(14):1456-65
references.pmid: 17021321
references.citation: Cancer Control. 2006 Dec;13 Suppl:26-31
references.pmid: 17242664
references.citation: Hematology. 2010 Oct;15(5):318-31
references.pmid: 20863427
references.citation: Lancet Oncol. 2010 Jan;11(1):29-37
references.pmid: 19853510
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12974-9
references.pmid: 19470455
references.citation: Haematologica. 2011 Jul;96(7):963-71
references.pmid: 21719884
references.citation: Leukemia. 2005 Aug;19(8):1424-31
references.pmid: 15920496
references.citation: Blood. 2008 Jan 1;111(1):86-93
references.pmid: 17893227
references.citation: Blood. 2011 Apr 28;117(17):4552-60
references.pmid: 21285439
references.citation: Cancer Control. 2006 Dec;13 Suppl:4-11
references.pmid: 17242661
references.citation: J Clin Oncol. 2010 May 1;28(13):2253-8
references.pmid: 20354132
references.citation: Am J Hematol. 2011 Jan;86(1):102-3
references.pmid: 21080340
references.citation: Blood. 2009 Jul 30;114(5):937-51
references.pmid: 19357394
references.citation: Nature. 2008 Jan 17;451(7176):335-9
references.pmid: 18202658
references.citation: Haematologica. 2008 Jul;93(7):967-72
references.pmid: 18591621
references.citation: Cancer. 2008 Sep 15;113(6):1351-61
references.pmid: 18618511
references.citation: Blood. 2009 Apr 23;113(17):3947-52
references.pmid: 18987358
references.citation: Blood. 1997 Mar 15;89(6):2079-88
references.pmid: 9058730
references.citation: Blood. 2011 Mar 3;117(9):2567-76
references.pmid: 21068437
references.citation: J Clin Invest. 2001 May;107(9):1049-54
references.pmid: 11342565
references.citation: Br J Haematol. 2010 Feb;148(3):483-4
references.pmid: 19874309
references.citation: J Clin Oncol. 2008 Oct 20;26(30):4952-7
references.pmid: 18606983
references.citation: Nat Med. 2010 Jan;16(1):49-58
references.pmid: 19898489